Novavax’s Covid-19 vaccine nearly 90% effective in U.K. study, much less in South Africa
January 28, 2021 at 17:14 PM EST
The results make its candidate “the first vaccine to demonstrate not only high clinical efficacy against Covid-19 but also significant clinical efficacy against both the rapidly emerging U.K. and South Africa variants,” Novavax President and CEO Stanley Erck in a statement.
